QIAGEN NV's ticker is QGENXXXX and the CUSIP is N72482107. A total of 180 filers reported holding QIAGEN NV in Q2 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $41,233,000 | +2.1% | 1,471,580 | 0.0% | 1.21% | +28.9% |
Q3 2016 | $40,380,000 | -14.6% | 1,471,580 | -32.1% | 0.94% | -19.6% |
Q2 2016 | $47,279,000 | -1.7% | 2,167,768 | +0.7% | 1.17% | +9.5% |
Q1 2016 | $48,080,000 | +18.1% | 2,152,214 | +46.2% | 1.07% | +19.3% |
Q4 2015 | $40,696,000 | +24.9% | 1,471,848 | +16.6% | 0.90% | +1.6% |
Q3 2015 | $32,578,000 | -14.3% | 1,262,748 | -17.6% | 0.88% | +15.1% |
Q2 2015 | $37,996,000 | -1.6% | 1,532,748 | 0.0% | 0.77% | -0.6% |
Q1 2015 | $38,625,000 | -22.9% | 1,532,748 | -28.2% | 0.77% | -19.6% |
Q4 2014 | $50,112,000 | +23.6% | 2,136,076 | +19.9% | 0.96% | +16.1% |
Q3 2014 | $40,555,000 | -6.9% | 1,781,076 | 0.0% | 0.83% | +9.1% |
Q2 2014 | $43,547,000 | +15.9% | 1,781,076 | 0.0% | 0.76% | +13.0% |
Q1 2014 | $37,562,000 | -11.4% | 1,781,076 | 0.0% | 0.67% | -8.7% |
Q4 2013 | $42,407,000 | -16.0% | 1,781,076 | -24.5% | 0.73% | -20.3% |
Q3 2013 | $50,482,000 | +7.5% | 2,358,976 | 0.0% | 0.92% | +2.8% |
Q2 2013 | $46,967,000 | – | 2,358,976 | – | 0.90% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hardman Johnston Global Advisors LLC | 6,178,402 | $170,833,000 | 11.32% |
Tikvah Management LLC | 369,425 | $10,215,000 | 5.35% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 360,000 | $9,954,000 | 3.36% |
Opus Point Partners Management, LLC | 160,000 | $4,424,000 | 2.92% |
Exane Asset Management | 106,238 | $2,910,304,000 | 1.76% |
Douglas C. Lane & Associates, Inc. | 1,918,338 | $53,042,000 | 1.44% |
Granahan Investment Management | 1,051,000 | $29,060,000 | 1.00% |
CRAMER ROSENTHAL MCGLYNN LLC | 2,285,569 | $63,196,000 | 0.95% |
Sivik Global Healthcare LLC | 70,000 | $1,936,000 | 0.92% |
PURA VIDA INVESTMENTS, LLC | 78,668 | $2,175,000 | 0.92% |